• Objectionable Microorganisms in Biopharmaceutical Production – Risk Mitigation
  • Objectionable Microorganisms in Biopharmaceutical Production – Risk Mitigation

    • Speaker : Carl Patterson
    • Session Code : CPMAY2021
    • Date : 20th May 2021
    • Time : This Event is Over and the Recorded Copy is Available
    • Duration : 60 Mins

Objectionable microorganisms associated with a medical device or pharmaceutical product can cause a serious illness to a patient. By testing and identifying these microorganisms early in the manufacturing processes, controls can be put into place to prevent harm to the patients.


Objectionable microorganisms are considered, if discovered, harmful to the patients. By identifying and controlling these microorganisms, and putting the appropriate controls in place early in the pharmaceutical manufacturing or medical device manufacturing processes, problems in the patients can be prevented.


This webinar will review the regulations pertaining to objectionable microorganisms, agency expectations, methods to identify objectionable microorganisms, interpreting results, and controls to put into place. By knowing, where, when, why and how objectionable microorganisms exist, harmful consequences to the patients can be prevented.


Areas Covered in the Session :


  • Regulations pertaining to objectionable microorganisms
  • Knowing what microorganisms are considered objectionable
  • The importance of knowing what microorganism are there in your product
  • Identifying objectionable microorganisms
  • Sources of microorganisms in pharmaceutical manufacturing facility
  • How to determine if you have an objectionable microorganism
  • Tests to determine objectionable microorganisms
  • Methods to control and reduce the amount of objectionable microorganisms


Who Should Attend:


  • Quality Assurance Departments
  • Quality Control Departments
  • Microbiology Analysts and Technicians
  • Regulatory Affairs Departments
  • Manufacturing Departments
  • Engineering Departments
  • Operations Departments
  • Production Departments
  • Logistics Departments
  • Consultants

Carl Patterson is a seasoned Pharmaceutical Manufacturing, Aseptic Processing, and Quality Assurance Professional who is based in San Diego, California. As soon as he discovered the importance of biotechnology in the area, he was inspired to enter the pharmaceutical manufacturing industry. However, his avid interest in all things biology, microbiology, and biochemistry officially began when he served in the U.S. Army as a Preventative Medicine Specialist and a Licensed Vocational Nurse.


To date, Carl has now garnered over two decades’ worth of extensive hands-on expertise. Currently, he is the Chief Consultant of his very own consultant business called aseptic-process.net, where he specializes in the aseptic processing of pharmaceutical products in the pharmaceutical manufacturing sector. Recently, he is in the process of creating webinars so he can share pertinent information about pharmaceutical manufacturing from a microbiological perspective.


Furthermore, Carl holds various degrees and certifications, including an M.S. in Biomedical Quality Systems from San Diego State University, a B.S. in Microbiology from the University of Texas, and Specialized Certificates in QA/QC & Biotechnology from UCSD.

Write a review

Please login or register to review

Enrollment Options


Tags: Objectionable Microorganisms, carl patterson, may 2021, webinar, amorit education